Top

Clinical Research in Cardiology

Published in:

01-01-2014 | Letter to the Editors

Early reduction of therapy-resistant hypertension in a patient after single-sided renal denervation approach

Authors: Marco R. Schroeter, Michael Koziolek

Published in: Clinical Research in Cardiology | Issue 1/2014

Excerpt

Sirs, …

Esler MD, Krum H, Sobotka PA et al (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376:1903–1909PubMedCrossRef

Mahfoud F, Lüscher TF, Andersson B et al (2013) Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J 34:2149–2157PubMedCrossRef

Damascelli B, Patelli G, Tichá V et al (2013) Catheter-based radiofrequency renal sympathetic denervation for resistant hypertension. J Vasc Interv Radiol 24:632–639PubMedCrossRef

Václavík J, Táborský M, Richter D (2013) Unilateral catheter-based renal sympathetic denervation in resistant arterial hypertension shows no blood pressure-lowering effect. Clin Exp Hypertens 35:192–194PubMedCrossRef

Mahfoud F, Cremers B, Janke J et al (2012) Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension 60:419–424PubMedCrossRef

Sobotka PA, Mahfoud F, Schlaich MP et al (2011) Sympatho-renal axis in chronic disease. Clin Res Cardiol 100:1049–1057PubMedCentralPubMedCrossRef

Brandt MC, Mahfoud F, Reda S et al (2012) Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 59:901–909PubMedCrossRef

Hering D, Lambert EA, Marusic P et al (2013) Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension 61:457–464PubMedCrossRef

Vollmann D, Sossalla S, Schroeter MR et al (2013) Renal artery ablation instead of pulmonary vein ablation in a hypertensive patient with symptomatic, drug-resistant, persistent atrial fibrillation. Clin Res Cardiol 102:315–318PubMedCentralPubMedCrossRef

10.

Ukena C, Bauer A, Mahfoud F et al (2012) Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol 101:63–67PubMedCrossRef

11.

Rippy MK, Zarins D, Barman NC et al (2011) Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol 100:1095–1101PubMedCrossRef

Title: Early reduction of therapy-resistant hypertension in a patient after single-sided renal denervation approach
Authors: Marco R. Schroeter
Michael Koziolek
Publication date: 01-01-2014
Publisher: Springer Berlin Heidelberg
Published in: Clinical Research in Cardiology / Issue 1/2014
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-013-0634-6

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Early reduction of therapy-resistant hypertension in a patient after single-sided renal denervation approach

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2014

Reported underuse of risk scores in patients with acute coronary syndromes without persistent ST elevations in clinical practice: results of a survey of the ALKK study group

Closure of a coronary to pulmonary artery fistula by radiofrequency catheter ablation in the pulmonary artery

Prevalence of different forms of infarct-atypical late gadolinium enhancement in patients early and late after heart transplantation

Coronary vasomotor abnormalities in patients with stable angina after successful stent implantation but without in-stent restenosis

Incidence and impact on prognosis of bleeding during percutaneous coronary interventions in patients with chronic kidney disease

Epidemiology of Chagas disease in Europe: many calculations, little knowledge

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page